• News
  • SAN DIEGO
  • General

Isis rings bell at Nasdaq

After making a presentation before one of Wall Street's key biotech investment conferences, Lynne Parshall, chief operating officer of Isis Pharmaceuticals Inc. (Nasdaq: ISIS), will ring the closing bell at the Nasdaq stock exchange Friday.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Isis Pharmaceuticals Inc.

Company Website

1896 Rutherford Road
Carlsbad, CA 92008

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ISIS
42.28
  0.40  
+ 0.96%
3,142,165,000
62.66
22.25

Insider Trade Data

Date Insider Shares Type Value
09/02/2014 O, Neil Patrick R 1,500 Sell $60,660
09/02/2014 O, Neil Patrick R 1,500 Exchange $15,435
09/02/2014 Parshall, B Lynne 11,071 Sell $445,507
09/02/2014 Parshall, B Lynne 11,071 Exchange $112,574
08/27/2014 Bennett, C Frank 5,000 Sell $202,630

Isis Pharmaceuticals Inc. Executive(s):

Stanley Crooke

  • Chief Executive Officer, Founder, President, Chairman

Similar Companies

NAICS - 325414 - Biological Product (except Diagnostic) Manufacturing
SIC - 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Subscribe Today!